BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16610577)

  • 1. Rhabdomyolysis after ingestion of "foxy," a hallucinogenic tryptamine derivative.
    Alatrash G; Majhail NS; Pile JC
    Mayo Clin Proc; 2006 Apr; 81(4):550-1. PubMed ID: 16610577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fatal poisoning with 5-methoxy-N,N-diisopropyltryptamine, Foxy.
    Tanaka E; Kamata T; Katagi M; Tsuchihashi H; Honda K
    Forensic Sci Int; 2006 Nov; 163(1-2):152-4. PubMed ID: 16406422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foxy, a designer tryptamine hallucinogen.
    Meatherall R; Sharma P
    J Anal Toxicol; 2003; 27(5):313-7. PubMed ID: 12908946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foxy methoxy: a new drug of abuse.
    Smolinske SC; Rastogi R; Schenkel S
    J Med Toxicol; 2005 Dec; 1(1):22-5. PubMed ID: 18072099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A foxy intoxication.
    Wilson JM; McGeorge F; Smolinske S; Meatherall R
    Forensic Sci Int; 2005 Feb; 148(1):31-6. PubMed ID: 15607587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: identification and quantification of its urinary metabolites.
    Kamata T; Katagi M; Kamata HT; Miki A; Shima N; Zaitsu K; Nishikawa M; Tanaka E; Honda K; Tsuchihashi H
    Drug Metab Dispos; 2006 Feb; 34(2):281-7. PubMed ID: 16280455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N, N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity.
    Shulgin AT; Carter MF
    Commun Psychopharmacol; 1980; 4(5):363-9. PubMed ID: 6949674
    [No Abstract]   [Full Text] [Related]  

  • 8. New drugs of abuse update: Foxy Methoxy.
    Muller AA
    J Emerg Nurs; 2004 Oct; 30(5):507-8. PubMed ID: 15452541
    [No Abstract]   [Full Text] [Related]  

  • 9. Rhabdomyolysis After LSD Ingestion.
    Berrens Z; Lammers J; White C
    Psychosomatics; 2010; 51(4):356-356.e3. PubMed ID: 20587768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in DMT and other tryptamine use among young adults in the United States.
    Palamar JJ; Le A
    Am J Addict; 2018 Oct; 27(7):578-585. PubMed ID: 30260086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-methoxy-N,N-di(iso)propyltryptamine hydrochloride (Foxy)-induced cognitive deficits in rat after exposure in adolescence.
    Compton DM; Dietrich KL; Selinger MC; Testa EK
    Physiol Behav; 2011 May; 103(2):203-9. PubMed ID: 21295050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe rhabdomyolysis, acute renal failure and posterior encephalopathy after 'magic mushroom' abuse.
    Bickel M; Ditting T; Watz H; Roesler A; Weidauer S; Jacobi V; Gueller S; Betz C; Fichtlscherer S; Stein J
    Eur J Emerg Med; 2005 Dec; 12(6):306-8. PubMed ID: 16276262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged delusional state triggered by repeated ingestion of aromatic liquid in a past 5-methoxy-N, N-diisopropyltryptamine abuser.
    Fuse-Nagase Y; Nishikawa T
    Addict Sci Clin Pract; 2013 Apr; 8(1):9. PubMed ID: 23577618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An examination of the effects of 5-Methoxy-n, n-di(ISO)propyltryptamine hydrochloride (Foxy) on cognitive development in rats.
    Compton DM; Selinger MC; Testa EK; Larkins KD
    Psychol Rep; 2006 Jun; 98(3):651-61. PubMed ID: 16933659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical chemistry of synthetic routes to psychoactive tryptamines. Part I. Characterisation of the Speeter and Anthony synthetic route to 5-methoxy-N,N-diisopropyltryptamine using ESI-MS-MS and ESI-TOF-MS.
    Brandt SD; Freeman S; Fleet IA; McGagh P; Alder JF
    Analyst; 2004 Nov; 129(11):1047-57. PubMed ID: 15508033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hallucinogenic world of tryptamines: an updated review.
    Araújo AM; Carvalho F; Bastos Mde L; Guedes de Pinho P; Carvalho M
    Arch Toxicol; 2015 Aug; 89(8):1151-73. PubMed ID: 25877327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute confusional state after designer tryptamine abuse.
    Itokawa M; Iwata K; Takahashi M; Sugihara G; Sasaki T; Abe Y; Uno M; Hobo M; Jitoku D; Inoue K; Arai M; Yasuda I; Shintani M
    Psychiatry Clin Neurosci; 2007 Apr; 61(2):196-9. PubMed ID: 17362440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative method for simultaneous determination of 5-methoxy-N,N-diisopropyltryptamine and its metabolites in urine using liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Jin MJ; Jin C; Kim JY; In MK; Kwon OS; Yoo HH
    J Forensic Sci; 2011 Jul; 56(4):1044-8. PubMed ID: 21418218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel synthetic cannabinoid (Cumyl-4-cyano-BINACA) resulting in hyperthermia, rhabdomyolysis, and renal failure in a 29-year-old patient: it's not meningitis
    El Zahran T; Gerona R; Morgan BW; Pomerleau AC
    Clin Toxicol (Phila); 2019 Jun; 57(6):421-422. PubMed ID: 30442067
    [No Abstract]   [Full Text] [Related]  

  • 20. Hair dye poisoning and rhabdomyolysis.
    Bokutz M; Nasir N; Mahmood F; Sajid S
    J Pak Med Assoc; 2015 Apr; 65(4):425-6. PubMed ID: 25976581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.